Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3 β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival.

MLA

Kim, Jee-Eun, et al. “Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3 β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival.” BioMed Research International, vol. 2017, 2017, p. 4163839. EBSCOhost, https://doi.org/10.1155/2017/4163839.

APA

Kim, J.-E., Lim, J. H., Jeon, G. S., Shin, J.-Y., Ahn, S.-W., Kim, S. H., Lee, K.-W., Hong, Y.-H., & Sung, J.-J. (2017). Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3 β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival. BioMed Research International, 2017, 4163839. https://doi.org/10.1155/2017/4163839

Chicago

Kim, Jee-Eun, Jung Hyun Lim, Gye Sun Jeon, Je-Young Shin, Suk-Won Ahn, Seung Hyun Kim, Kwang-Woo Lee, Yoon-Ho Hong, and Jung-Joon Sung. 2017. “Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3 β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival.” BioMed Research International 2017: 4163839. doi:10.1155/2017/4163839.